Timothy E. Kute
- Cancer Research top 1%
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 7
- Oncology top 1%
- HER2/EGFR in Cancer Research 11
- Cancer Cells and Metastasis 6
-
- Monoclonal and Polyclonal Antibodies Research 10
- Molecular Biology top 5%
- Retinoids in leukemia and cellular processes 6
-
- Estrogen and related hormone effects 15
-
- Ovarian cancer diagnosis and treatment 5
- Co-authors
- Hyman B. MussDonald A. BerryMaurice BarcosConstance CirrincioneDaniel R. BudmanAnn D. ThorF. KoernerI. Craig Henderson
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Timothy E. Kute
77 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 1.3k
- Oncology 2.0k
- Radiology, Nuclear Medicine and Imaging 688
- Pathology and Forensic Medicine 500
- Molecular Biology 1.8k
Countries citing papers authored by Timothy E. Kute
This map shows the geographic impact of Timothy E. Kute's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy E. Kute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy E. Kute more than expected).
Fields of papers citing papers by Timothy E. Kute
This network shows the impact of papers produced by Timothy E. Kute. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy E. Kute. The network helps show where Timothy E. Kute may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Timothy E. Kute, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 77 | |
| 2 | 2010 | 37 | |
| 3 | JAB1 confers resistance to trastuzumab by inhibition of p27 | 2007 | 1 |
| 4 | 2006 | 76 | |
| 5 | 2005 | 55 | |
| 6 | 2004 | 16 | |
| 7 | 2002 | 55 | |
| 8 | 2001 | 26 | |
| 9 | 2001 | 51 | |
| 10 | 1999 | 157 | |
| 11 | 1997 | 81 | |
| 12 | An immunohistochemical analysis of NM23 expression in breast cancer | 1996 | 1 |
| 13 | 1995 | 26 | |
| 14 | 1995 | 20 | |
| 15 | 1991 | 10 | |
| 16 | 1990 | 78 | |
| 17 | 1990 | 9 | |
| 18 | 1989 | 2 | |
| 19 | Proliferation-dependent cytotoxicity of methotrexate in murine L5178Y leukemia. | 1988 | 9 |
| 20 | Molecular heterogeneity of cytosolic forms of estrogen receptors from human breast tumors. | 1978 | 47 |
About Timothy E. Kute
Timothy E. Kute is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Immunology and Allergy and Pathology and Forensic Medicine, having authored 78 papers that have together received 4.2k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (15 papers), HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Breast Cancer Treatment Studies (8 papers), Cancer Genomics and Diagnostics (7 papers), Cancer Cells and Metastasis (6 papers), Retinoids in leukemia and cellular processes (6 papers) and Ovarian cancer diagnosis and treatment (5 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (2.0k citations), Radiology, Nuclear Medicine and Imaging (688 citations), Pathology and Forensic Medicine (500 citations) and Molecular Biology (1.8k citations). Timothy E. Kute has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Hyman B. Muss, Donald A. Berry, Maurice Barcos, Constance Cirrincione, Daniel R. Budman, Ann D. Thor, F. Koerner, I. Craig Henderson, Edison T. Liu and William C. Wood. Their work appears in journals such as Cancer, Cytometry, Breast Cancer Research and Treatment, American Journal of Obstetrics and Gynecology and Archives of Pathology & Laboratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.